OOIR: Observatory of International Research

Papers

(The TQCC of Current Hematologic Malignancy Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Monoclonal Gammopathy-Associated Neuropathy	128
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions	31
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations	25
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations	21
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications	19
Management of Chronic Myeloid Leukemia in Children and Young Adults	18
Value in Myeloma Care: Myth or Reality	17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities	17
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease	17
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications	16
Targeting Apoptosis in ALL	15
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer	15
Transplantation and Cellular Therapy for Older Adults—The MSK Approach	14
Allogeneic Transplant for CMML	13
Multidisciplinary Approach to Older Adults with Hematologic Malignancies—a Paradigm Shift	13
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders	13
Prognostic and Predictive Models in Myelofibrosis	13
How Do We Manage Chronic Lymphocytic Leukemia in India	12
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications	11
Multiple Myeloma: Current Clinical Landscape and Compounding Costs	11
Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies	11
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia	10
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults	9
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies	8
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders	8

Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders	8
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies	8
CAR-T Cell Therapy: the Efficacy and Toxicity Balance	8
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia	8
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma	8
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia	8